Sickle cell disease is a genetic blood disorder that affects the structure and function of hemoglobin, reduces the ability of red blood cells to transport oxygen efficiently, and progresses to a chronic vascular disease that affects approximately 100,000 Americans and millions worldwide, with a disproportionate effect on the Black community.
The post Sickle Cell Clinical Trial Aims to Cure Disease by Correcting Patient’s Mutated Gene first appeared on Post News Group.
